Human papillomavirus (HPV) infection
50 results
1 - 50
Human papillomavirus (HPV) infection - Vaccines in alphabetical order
HPV vaccine not effective in treating women with preexisting HPV infection- Warts (verruca vulgaris)
- Male circumcision prevents HSV-2 and HPV infection
- Effect of Human Papillomavirus 16/18 L1 virus like particle vaccine among women with pre-existing infection
- Oncogenic HPV in men: low incidence, high rate of spontaneous clearance (HIM)
- Sexually transmitted infections
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: Cochrane systematic review- Follow‐up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
- Syphilis
- Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions
- Majority of CIN2 regress in women aged 25 to 30 years
- Dyspareunia in women
- Viral infections of the oral mucosa
- Imiquimod effective for vulvar intraepithelial neoplasia
- Cytology versus HPV testing for cervical cancer screening in the general population
- Balanitis, balanoposthitis and paraphimosis in the adult
- Benign gynaecological lesions and tumours
- Interventions for anal canal intraepithelial neoplasia
- Gynaecological cancers
- Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
- HPV vaccines against human papillomavirus
- Interventions for encouraging sexual behaviours intended to prevent cervical cancer
- Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
- Pap (cervical) smear and endometrial biopsy
- Improving vaccination uptake among adolescents
- Interventions targeted at women to encourage the uptake of cervical screening
- Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia